TOPIC

Keep it simple – Ready-To-Use Cav1.2 cells on Qube 384

Journal

Application Report

Author(s)

Melanie Schupp

Year

2020

CiPA recommended CaV1.2 assay protocols were run on Qube
384 using Ready-To-Use (RTU) CaV1.2 cells from NMI TT with
~80% success rate, low run-down and reliable pharmacology.
We demonstrate the quality and versatility of ready-to-use CaV1.2 cells, but also that RTU cells can be a valuable addition to the laboratory tool pack to 1) decrease variation from cell culture and 2) decrease dependence on skilled cell culture personnel.

• Ready-to-use cells easily ignites your experiment within
minutes
• Up to 82% success rate
• Reliable pharmacology including safety pharmacology
recommended by CiPA
• Rundown of only +0.2% ± 0.06% per minute

Go to journal

Get in Touch

We strive to provide the best for our customers, and we are always ready to help. Please let us know if you have a question for us.

Follow us